Efficacy and safety of community-based moxibustion for primary hypertension: A randomized controlled trial with patient preference arms.

ABSTRACT: Moxibustion has been shown to have a potential antihypertensive effect, but its applicability for the primary care of hypertension is unclear. The authors conducted a multicenter randomized controlled trial (RCT) with patient preference arms to investigate the effect, safety, cost-effectiveness, and compliance of moxibustion in community patients with hypertension. Patients with primary hypertension were enrolled from seven communities randomly or nonrandomly assigned to receive self-administered moxibustion + the original hypertensive regimen or the original hypertensive regimen alone for 6 months. The authors mainly evaluated the effects of moxibustion on hypertensive outcomes and adverse events. As a result, a total of 160 and 240 patients were recruited into the randomized and nonrando

SUBMITTER: Zhou X 

PROVIDER: S-EPMC10710558 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature